The coronavirus pandemic continues to reshape our country and the world, particularly when it comes to challenging the perception of “what’s possible” in biopharmaceutical innovation. Recently, PhRMA sponsored STAT News’ 2020 health summit convening leading health care CEOs, researchers, thought leaders, policymakers, physicians and health policy experts. PhRMA President and CEO Stephen J. Ubl along with David Ricks, chairman and CEO of Eli Lilly and Company and Kabir Nath, president and CEO of Otsuka North America Pharmaceutical Business discussed the biopharmaceutical industry’s role in addressing COVID-19 and how biopharmaceutical researchers are collaborating across the research and development ecosystem to identify and advance solutions to beat the pandemic.

When

November 16–18, 2020 

Speakers:

• Stephen J. Ubl, President and Chief Executive Officer, PhRMA
  • Watch interview here with STAT News’ Matthew Herper
• David A. Ricks, Chairman and Chief Executive Officer, Eli Lilly; incoming Chairman of the Board, PhRMA
• Kabir Nath, President and CEO, Otsuka North America Pharmaceutical Business